Advances in biomarker development are revolutionizing the way we study, diagnose
and treat disease. However, progress in the development and use of biomarkers
for diseases of the central nervous system has been limited by a number of
difficulties -- including the inherent barriers associated with studying the
brain. Development of reliable biomarkers for brain disorders would dramatically
accelerate research on the etiology, pathophysiology, disease progression, and
therapeutic development of many very prevalent and devastating diseases
including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and
others. International experts in the field have contributed chapters to this
volume that discuss the latest advances in biomarker technologies and biomarker
development for brain disorders,